BioAmber Inc.
Materials · Industrial Organic Chemicals · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1M | $1.5M | $367,249 | $350,661 | $2.7M | $2.3M |
| Operating income | −$10.6M | −$8.5M | −$38.5M | −$35.2M | −$41.2M | −$39.1M |
| Net income | $105,833 | −$10.9M | −$37.2M | −$46.5M | −$27.4M | −$39.4M |
| Total assets | $69.5M | $161.3M | $141.8M | $152.4M | $114.1M | $50.0M |
| Total liabilities | $47.7M | $75.3M | $70.8M | $72.2M | $46.9M | $12.2M |
| Equity | $21.9M | $48.5M | $46.4M | $56.1M | $65.0M | $35.0M |
| EPS (diluted) | $0.00 | $-0.39 | $-1.52 | $-2.32 | $-1.75 | $3.82 |
| Shares out. | 34.8M | 28.8M | 21.8M | 18.6M | 18.6M | 10.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −500.5%
- Net margin
- 5.0%
- Return on equity
- 0.5%
- Return on assets
- 0.2%
- Return on capital (ROCE)
- −18.3%
- Liabilities / assets
- 68.6%
- Debt / equity
- 2.18×
- Book value / share
- $0.63
- Revenue growth (YoY)
- 45.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- -15.13distress
- Accruals / assets
- 43.0%high accruals
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 3 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 9, 2018
- NT 10-Kmissed a reporting deadline ↗Mar 15, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Wall Kenneth W.Director | Nov 30, 2017 | Buy | 40,000 | $0.43 |
| Hartmann Michael A.Officer — Executive Vice President | Aug 18, 2017 | Buy | 10,000 | $0.47 |
| Haller HeinzDirector | Aug 15, 2017 | Buy | 40,000 | — |
| Briner Kurt WDirector | Aug 15, 2017 | Buy | 133,333 | — |
| Millis JamesOfficer — Chief Technology Officer | Aug 15, 2017 | Buy | 13,333 | — |
| Richstone Ellen BDirector | Aug 15, 2017 | Buy | 13,333 | — |
| Settino MarioOfficer — Chief Financial Officer | Aug 15, 2017 | Buy | 20,000 | — |
| Land Raymond JDirector | Aug 15, 2017 | Buy | 13,333 | — |
| Land Raymond JDirector | Aug 15, 2017 | Buy | 40,000 | — |
| Hartmann Michael A.Officer — Executive Vice President | Aug 15, 2017 | Buy | 13,333 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Other material eventOct 26, 2018
- Director / officer changeSep 4, 2018
- Other material eventAug 14, 2018
- Other material eventAug 1, 2018
- Other material eventJun 20, 2018
- Bankruptcy or receivershipMay 8, 2018
- Delisting / listing-standard notice · Regulation FD disclosureFeb 16, 2018
- Regulation FD disclosureFeb 15, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AAMENDMENT NO. 3 TO SCHEDULE 13GAug 9, 2019
- SC 13G/AAug 8, 2019
- SC 13G/AG/A2Jul 26, 2019
- SC 13G/AJul 22, 2019
- SC 13GJul 9, 2019
- SC 13GJul 9, 2019
- SC 13D/AFeb 14, 2019
- SC 13G/AAMENDMENT NO. 1 TO SCHEDULE 13GFeb 8, 2019
- SC 13G/ASABBY 13G-A BIOAQ 1.03.19Jan 3, 2019
- 8-KOct 26, 2018
- 8-KSep 4, 2018
- 8-KAug 14, 2018
- 8-KAug 1, 2018
- 8-KJun 20, 2018
- SC 13G/ASCHEDULE 13G AMENDMENT NO. 2Jun 7, 2018